Marcia Eisenberg, Chief Scientific Officer of LabCorp Diagnostics, to Join OmniSeq’s Board of Directors BUFFALO, N.Y., Aug. 21, 2017 (GLOBE NEWSWIRE) — OmniSeq, Inc., a molecular diagnostics subsidiary of the…
Read More
Twitter Feed
Join Dr. Gajewski tomorrow and learn about the cancer #immunotherapy revolution at this FREE community event #CRISummit17 https://t.co/HZWJX7NQQv
Plenty of questions remain about how genomic tests should be reported, panel says
https://t.co/D8cFCFiokK
Gottlieb @US_FDA :Prolonging progress on drugs to get perfect data does not serve patients waiting @postlive #chasingcancer @lauriemcginley2
William Nelson @HopkinsMedicine: Environment around cancer is essential: many different immune and cancer cells. @postlive #chasingcancer
Gottlieb @US_FDA : Likely to see more outcomes based pricing @postlive #chasingcancer @lauriemcginley2
